Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Clin Med ; 13(14)2024 Jul 18.
Article in English | MEDLINE | ID: mdl-39064247

ABSTRACT

Background: This cohort study was conducted to devise an approximation formula for predicting the glomerular filtration rate (GFR) after 1 year using annual medical examination data from the general population. Methods: Consecutive annual medical examination data were obtained for 41,337 inhabitants. Machine learning with the random forest method was used to assess the importance of each clinical parameter in terms of its association with estimated GFR (eGFR) after 1 year. An approximation formula was developed by multiple linear regression analysis based on the four most important clinical parameters. The relationship between the GFR after 1 year approximated by our formula and the eGFR after 1 year was analyzed using Pearson's correlation coefficient. Results: The following approximation formula was obtained by multiple linear regression analysis: approximate GFR after 1 year (mL/min/1.73 m2) = -0.054 × age + 0.162 × hemoglobin - 0.085 × uric acid + 0.849 × eGFR + 11.5. The approximate GFR after 1 year was significantly and strongly correlated with the eGFR at that time (r = 0.884; p < 0.001). Conclusions: An approximation formula including age, hemoglobin, uric acid, and eGFR may be useful for predicting GFR after 1 year among members of the general population.

2.
J Smooth Muscle Res ; 56(0): 69-81, 2020.
Article in English | MEDLINE | ID: mdl-33473062

ABSTRACT

Gastric contractions show two specific patterns in many species, migrating motor contractions (MMC) and postprandial contractions (PPCs), that occur in the fasted and fed states, respectively. In this study, we examined the role of somatostatin (SST) in gastric motility both in vivo and in vitro using the Asian house shrew (Suncus murinus). We performed in vivo recordings of gastric motility and in vitro organ bath experiments using S. murinus, which was recently established as a small laboratory animal for use in tests of gastrointestinal motility. SST (1.65 µg kg-1 min-1) was intravenously administered during phase II of MMC and PPCs. Next, the effect of SST on motilin-induced gastric contractions at phase I of MMC was measured. Cyclosomatostatin (CSST), an SST receptor antagonist, was administered at the peak of phase III of MMC. In addition, the effect of SST (10-11-10-9 M) on motilin-induced gastric contractions was evaluated using an organ bath experiment in vitro. In conscious, free-moving S. murinus, the administration of SST decreased the occurrence of the spontaneous phase II of MMC and PPCs. Pretreatment with SST and octreotide suppressed the induction of motilin-induced gastric contractions both in vivo and in vitro. Administration of CSST before the peak of spontaneous phase III contractions had no effect on gastric contractions. Endogenous SST is not involved in the regulation of gastric MMC and PPCs, but exogenous SST suppresses spontaneous gastric contractions. Thus, SST would be good for treating abnormal gastrointestinal motility disorders.


Subject(s)
Gastrointestinal Motility/drug effects , Somatostatin/pharmacology , Animals , Depression, Chemical , Female , In Vitro Techniques , Male , Motilin/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Myoelectric Complex, Migrating/drug effects , Postprandial Period , Shrews , Somatostatin/physiology , Somatostatin/therapeutic use
3.
Tokai J Exp Clin Med ; 44(4): 118-123, 2019 Dec 20.
Article in English | MEDLINE | ID: mdl-31769002

ABSTRACT

OBJECTIVE: Proteinuria is a marker for cardiovascular diseases and all-cause mortality. In the Specific Health Checkups in Japan, when subjects show trace proteinuria (grade±) on dipstick assay, further examination is recommended to them. Although 150 mg/gCr is a threshold for diagnosing chronic kidney disease (CKD), little data on the relationship between dipstick grade± and the protein-creatinine ratio have been reported. METHODS: A cross-sectional study using urine specimens obtained in a single institute, JCHO Saitama Northern Medical Center, was performed from October 2014 to March 2016. The level of proteinuria was measured in fresh morning urine samples from 819 volunteer participants of the Specific Health Checkups by two methods: Eiken Uropaper III to detect and qualitatively grade proteinuria, and total protein concentration by the pyrogallol red method. RESULTS: Sensitivity, specificity, and the positive likelihood ratio to detect proteinuria of 30 mg/dL by 1+ were 90.3%, 97.8%, and 41.9, whereas 150 mg/gCr by ± were 45.3%, 81.4%, and 2.4, respectively. Therefore, screening for 150 mg/gCr by dipstick grade± had a false-negative rate of 54.7% and false-negative rate was significantly higher in women (8.0%) than in men (1.7%) (p < 0.0001). CONCLUSIONS: Although the dipstick assay is useful to detect clinically significant proteinuria, substantial numbers of false-negative results occur in checkups for identifying subjects with a risk of CKD.


Subject(s)
Creatinine/urine , Proteinuria/urine , Renal Insufficiency, Chronic/urine , Urinalysis/methods , Adult , Aged , Cross-Sectional Studies , False Negative Reactions , Female , Humans , Limit of Detection , Male , Middle Aged , Prevalence , Proteinuria/epidemiology , Reagent Strips , Renal Insufficiency, Chronic/epidemiology , Sensitivity and Specificity , Sex Factors , Urinalysis/instrumentation
4.
Chem Asian J ; 10(10): 2112-6, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25873417

ABSTRACT

The origin of higher reactivity in water-accelerated asymmetric aldol reactions with our designed primary amine organocatalyst was elucidated by both computational and experimental methods. As suggested by the calculated transition-state structures for water-promoted imine-enamine isomerization, anti-selective aldol reaction and hemiaminal formation, the rate of this aldol reaction was found experimentally to be even more accelerated by the addition of cis-2-butene-1,4-diol as additive.

6.
Metabolism ; 60(6): 823-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20817211

ABSTRACT

Although periodontal disease may be associated with increased risk for atherosclerosis, the mechanism by which the disease causes atherosclerosis is still unknown. The candidates contributing to atherosclerosis in periodontal disease include low-grade inflammation such as C-reactive protein (CRP) and insulin resistance. A previous study demonstrated that periodontal therapy leads to an improvement in CRP as well as insulin resistance, indicating the relationship between periodontal disease and low-grade inflammation or insulin resistance. On the other hand, we previously demonstrated that serum triglyceride (TG) per se is independently associated with CRP or insulin resistance in Japanese populations with a body mass index (BMI) of 21.5 to 27.0 (midrange BMI). To the best of our knowledge, however, the relationship between periodontal disease and serum TG is not fully clarified. The first aim of the present study is to investigate whether periodontal disease is associated with serum TG in Japanese subjects with midrange BMI. If so, another aim of the study is to determine which mechanism is responsible for the association between periodontal disease and serum TG in these subjects. We have performed a periodontal examination in the Ogaki metabolic syndrome medical examination. One hundred sixty-two participants from 40 to 74 years old (56 men and 106 women; mean age, 66.43 ± 6.25 years) were enrolled in the study. Besides medical examination, oral panoramic radiograph was taken for all participants. Average bone score was also calculated. Periodontal bone destruction increased according to the age of the participants (r = 0.227, P < .004, Spearman correlation coefficient). Periodontal bone destruction was also associated with serum TG levels (r = 0.299, P = .000). This association was more evident in subjects with midrange BMI (r = 0.332, P < .001). In subjects with midrange BMI, TG was not correlated with BMI or waste circumstances. Furthermore, TG was not associated with age itself in the midrange BMI group. We then investigated the lipolytic activity of endotoxin in cocultures of adipocytes and macrophages. Low-dose lipopolysaccharide dose-dependently increased lipolytic activity in cocultures, and this activity was neutralized by anti-tumor necrosis factor α neutralizing antibodies. These results suggest that periodontal infection, especially bacterial endotoxinemia, is associated with enhanced lipolysis and subsequent up-regulation of circulating TG in Japanese with midrange BMI.


Subject(s)
Hypertriglyceridemia/metabolism , Lipolysis/physiology , Periodontal Diseases/metabolism , 3T3-L1 Cells , Adult , Aged , Alveolar Bone Loss/complications , Alveolar Bone Loss/pathology , Animals , Antibodies, Blocking/pharmacology , Body Mass Index , Coculture Techniques , Dose-Response Relationship, Drug , Endotoxins/analysis , Female , Humans , Hypertriglyceridemia/complications , Hypertriglyceridemia/epidemiology , Japan/epidemiology , Lipolysis/drug effects , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Male , Mice , Middle Aged , Periodontal Diseases/complications , Periodontal Diseases/pathology , Triglycerides/blood , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Waist Circumference/physiology
7.
J Am Chem Soc ; 130(52): 17666-7, 2008 Dec 31.
Article in English | MEDLINE | ID: mdl-19055327

ABSTRACT

A novel approach for asymmetric synthesis of both enantiomeric aldol products has been developed by designing two different chiral organocatalysts from a readily available, protected cis-diamine compound as a common chiral source. This approach would be very useful from a practical viewpoint.

8.
Bone ; 39(3): 453-9, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16581323

ABSTRACT

The effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate, a representative anti-resorptive drug, on trabecular microarchitecture and biomechanical properties were investigated in mature estrogen-deficient rats; and effects which affected microstructural components that contributed to the improvement of bone strength were also determined. Thirty-three-week-old OVX rats were treated with various doses of ONO-4819, risedronate, or their combination for 11 weeks. Bone mineral density (BMD), trabecular microstructure, and biomechanical strength were determined at the proximal tibia by peripheral quantitative CT, micro CT, and finite element analysis, respectively. Bone histomorphometry was performed at the same site. The results of trabecular structure analysis indicated that whereas risedronate functioned mainly in maintaining trabecular connectivity, ONO-4819 converted the fragile rod-like trabeculae caused by estrogen deficiency to a plate-like structure. In addition, ONO-4819 is one of the few drugs that are capable of increasing trabecular thickness. When the 2 drugs were combined, the beneficial effects of each drug on the trabecular microarchitecture were maintained, resulting in their additive effects on bone strength. The results of bone histomorphometry suggest that ONO-4819 caused an increase in the rate of bone formation by stimulating the differentiation/recruitment of osteoblasts as well as their mineralizing function. ONO-4819 did not stimulate bone resorption, but rather exerted an anti-resorptive function within a certain dose range. ONO-4819 and risedronate increased BMD and improved trabecular structure and biomechanical strength in an additive and independent manner. Thus, EP4 agonist ONO-4819 in combination with risedronate may be an effective treatment for osteoporosis.


Subject(s)
Aging/physiology , Etidronic Acid/analogs & derivatives , Heptanoates/pharmacology , Ovariectomy , Prostaglandins E/agonists , Tibia/cytology , Tibia/drug effects , Animals , Bone Density/drug effects , Etidronic Acid/pharmacology , Female , Rats , Rats, Sprague-Dawley , Risedronic Acid , Stress, Mechanical , Tibia/physiology
9.
J Biosci Bioeng ; 94(3): 207-11, 2002.
Article in English | MEDLINE | ID: mdl-16233293

ABSTRACT

The polyol macrolide niphimycin (NM) exhibited fungicidal activity against Saccharomyces cerevisiae cells accompanying the leakage of cytoplasmic components including nucleotide-like materials in addition to K+ at 10 microM or above. Such a dynamic change in the plasma membrane was observed upon treatment of cells with H2O2 but not with the polyene macrolide antibiotic amphotericin B (AmB). The NM-induced cell death could be prevented by the exogenous addition of phosphatidylcholine (PC) whereas such a protective effect was only weakly observed with ergosterol, the molecular target of AmB. NM-treated cells were further characterized with a dramatic loss of glutathione even at a dose of 5 microM or less, representing NM-triggered metabolic conversion of the antioxidant molecule. NM-treatment indeed accelerated the cellular production of reactive oxygen species (ROS) such as H2O2 detectable with a specific fluorescent probe in a dose-dependent manner. These results suggested a synergistic combination of direct plasma membrane damage and oxidative stress as a cause of antifungal activity of NM against S. cerevisiae.

10.
J Biosci Bioeng ; 94(3): 258-63, 2002.
Article in English | MEDLINE | ID: mdl-16233300

ABSTRACT

A long-chain acyl-CoA synthetase (Faap) inhibitor, adenosine 5'-hexadecylphosphate (AMPC16), caused lethal plasma membrane damage to Saccharomyces cerevisiae cells as reflected by the leakage of cytoplasmic K+ into medium in which Mg2+ was supplemented at 10 mM. AMPC16 did not interfere with the de novo synthesis of phospholipids using acetyl-CoA as a starting material, but the AMP analog accelerated the liberation of long- chain fatty acids from phospholipids with the aid of exogenous Mg2+, suggesting that the role of this divalent cation is to maximize the rate of the acyl group turnover. This Mg2+-dependent fungicidal effect of AMPC16 was similarly observed with a mutant lacking any of the phospholipase B (Plbp) isozymes, whereas it was mostly suppressed in a phospholipase C (Plc1p) deletion mutant in which the liberation of fatty acids from phospholipids was completely prevented. These results suggest that Plc1p is normally functional for phospholipid reconstitution in exponentially growing cells and enhancement of its activity by exogenous Mg2+ could be a cause of the irreversible deacylation of plasma membrane phospholipids when their reacylation is blocked at the step of activation of long-chain fatty acids by one of the Faap isozymes.

11.
Microbiology (Reading) ; 146 ( Pt 2): 377-384, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10708376

ABSTRACT

One of the long-chain alkyl esters of AMP, adenosine 5'-hexadecylphosphate (AMPC16), exhibited a cytotoxic growth inhibitory effect on cells of various yeast strains. The growth inhibitory effect of AMPC16 on Saccharomyces cerevisiae cells was observed only in medium containing Mg2+, which accelerated cellular uptake of the nucleotide analogue. In the presence of Mg2+, AMPC16 completely inhibited glucose-induced extracellular acidification by the intact cells and also interfered with activation of the plasma membrane ATPase, but did not directly inhibit the ATPase activity itself. AMPC16 treatment prevented cells from increasing their intracellular sn-1,2-diacylglycerol (DAG) level in response to glucose, whereas the inhibition of proton extrusion by the cells could be largely reversed by the coaddition of a membrane-permeable DAG analogue. The DAG analogue, a physiological activator of protein kinase C (PKC), was not protective against the inhibition of glucose-induced proton extrusion by staurosporine, which is capable of directly interfering with the action of PKC. These results implied that AMPC16 caused a Mg(2+)-dependent cytotoxic effect on Sac. cerevisiae cells by interfering with a phosphatidylinositol type of signal that mediates activation of the plasma membrane proton pump.


Subject(s)
Adenosine Monophosphate/analogs & derivatives , Glucose/metabolism , Proton Pumps/metabolism , Proton-Translocating ATPases/metabolism , Saccharomyces cerevisiae/drug effects , Adenosine Monophosphate/chemistry , Adenosine Monophosphate/pharmacology , Cell Membrane/enzymology , Diglycerides/metabolism , Enzyme Activation , Glucose/pharmacology , Hydrogen-Ion Concentration , Magnesium/pharmacology , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...